MCR Disease Management of Metastatic Melanoma

Disease Management and Resource Use for the Management of Melanoma stage IIIc or IV Positive for BRAF V600 Mutations in Greece

Objective: Melanoma is one of the most aggressive cancers and is responsible for the majority of skin cancer deaths, with the
presence of metastases prognostic for poor survival. At a time when most cancer incidences are falling, the annual incidence
of melanoma has risen as rapidly as 4-6% in many European countries, with a substantial economic burden in advanced
stages. The objective of this study is the investigation of treatment pathways and healthcare resource use related to advanced
BRAF-mutated melanoma in Greece.

Continue reading

HOsmartAI

HosmartAI EU Project, an amazing and ambitious journey for Pharmecons Easy Access who will perform the economic evaluation of the AI technologies has just started!

On the last 9-10 February, took place the kick-off meeting of the new project HosmartAI –
“Hospital Smart development based on AI”. The project is funded by €10 million under European
Union’s Horizon 2020 research and innovation programme (Grant Agreement No 101016834).

Continue reading